|

Consolidation Chemotherapy Clinical Trials

3 actively recruiting trials

Also known as: CC

Pipeline

Phase 2/3: 1

Top Sponsors

  • Shandong Cancer Hospital and Institute1
  • National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos1
  • Larissa University Hospital1

Indications

  • Cancer3
  • Rectal Cancer2
  • Total Neoadjuvant Treatment1
  • Chemotherapy Side Effects1
  • Organ Preservation1

Other3 trials

Adaptive Boost Radiotherapy to Primary Lesions and Positive Nodes in the Neoadjuvant Treatment of Locally Advanced Rectal Cancer
Neoadjuvant Chemoradiotherapy and Consolidation Chemotherapy for Rectal Cancer: A Randomized Controlled Trial
N/A
Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer.
Phase 2/3

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.